MLICM
CDNA icon

Metropolitan Life Insurance Company (MetLife)’s CareDx CDNA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,759
Closed -$29.2K – 392
2024
Q1 		$29.2K Hold
2,759
– – ﹤0.01% 1672
2023
Q4 		$33.1K Hold
2,759
– – ﹤0.01% 1654
2023
Q3 		$19.3K Hold
2,759
– – ﹤0.01% 1917
2023
Q2 		$23.5K Hold
2,759
– – ﹤0.01% 1845
2023
Q1 		$25.2K Sell
2,759
-595
-18% -$7.61K ﹤0.01% 1762
2022
Q4 		$38.3K Hold
3,354
– – ﹤0.01% 1634
2022
Q3 		$57.1K Hold
3,354
– – ﹤0.01% 1369
2022
Q2 		$72K Hold
3,354
– – ﹤0.01% 1270
2022
Q1 		$124K Sell
3,354
-9,938
-75% -$387K ﹤0.01% 1070
2021
Q4 		$605K Hold
13,292
– – 0.01% 1296
2021
Q3 		$842K Sell
13,292
-497
-4% -$37.8K 0.01% 1093
2021
Q2 		$1.26M Buy
13,789
+493
+4% +$39.2K 0.02% 835
2021
Q1 		$905K Sell
13,296
-303
-2% -$23.5K 0.01% 1018
2020
Q4 		$985K Hold
13,599
– – 0.01% 894
2020
Q3 		$516K Hold
13,599
– – 0.01% 1196
2020
Q2 		$482K Hold
13,599
– – 0.01% 1229
2020
Q1 		$297K Hold
13,599
– – 0.01% 1361
2019
Q4 		$293K Hold
13,599
– – ﹤0.01% 1650
2019
Q3 		$307K Buy
13,599
+1,764
+15% +$48.8K 0.01% 1598
2019
Q2 		$426K Buy
11,835
+479
+4% +$15.3K 0.01% 1404
2019
Q1 		$358K Hold
11,356
– – 0.01% 1513
2018
Q4 		$285K Hold
11,356
– – 0.01% 1577
2018
Q3 		$328K Hold
11,356
– – 0.01% 1663
2018
Q2 		$139K Buy
+11,356
New +$130K ﹤0.01% 2152

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CDNA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CareDx (CDNA) in Q2 2024, closing a stake of 2,759 shares — an estimated $29.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CDNA in Q2 2018 and held it in 24 quarters. The position peaked at $1.26M in Q2 2021. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining CareDx position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,759 CareDx shares in Q2 2024, an estimated $29.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in CareDx in Q2 2018 and held it in 24 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s CareDx position peaked at $1.26M in Q2 2021.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.